Literature DB >> 17590239

A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau.

Roland Brandt1, Aikaterini Gergou, Irene Wacker, Thomas Fath, Harald Hutter.   

Abstract

The microtubule-associated tau proteins become functionally and structurally altered in Alzheimer's disease (AD). To analyze tau modification and its role in a non-vertebrate animal model, we produced transgenic Caenorhabditis elegans strains with a panneuronal expression of human tau and a pseudohyperphosphorylated (PHP) tau construct that mimics AD-relevant tau modification. We show that human tau in C. elegans becomes highly phosphorylated and exhibits conformational changes similar to PHP tau and human PHF tau. Both, wt tau and PHP tau induced a progressive age-dependent development of a phenotype of uncoordinated locomotion (unc) in the absence of neuronal degeneration. However, only PHP tau induced a defective pattern of motor neuron development as indicated by the presence of gaps in the dorsal cord, commissures on the wrong side and local broadening of axons. The data indicate that C. elegans is capable of highly phosphorylating human tau to an AD-like state whereas only stable disease-like tau modification induce developmental defects suggesting a specific interference of pathologic tau with intracellular mechanisms of axonal outgrowth and pathfinding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590239     DOI: 10.1016/j.neurobiolaging.2007.05.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  46 in total

1.  Caenorhabditis elegans as a model in developmental toxicology.

Authors:  Windy A Boyd; Marjolein V Smith; Jonathan H Freedman
Journal:  Methods Mol Biol       Date:  2012

2.  Neurotoxic effects of TDP-43 overexpression in C. elegans.

Authors:  Peter E A Ash; Yong-Jie Zhang; Christine M Roberts; Tassa Saldi; Harald Hutter; Emanuele Buratti; Leonard Petrucelli; Christopher D Link
Journal:  Hum Mol Genet       Date:  2010-06-08       Impact factor: 6.150

Review 3.  Strategies for automated analysis of C. elegans locomotion.

Authors:  Steven D Buckingham; David B Sattelle
Journal:  Invert Neurosci       Date:  2008-08-08

4.  A novel interaction between aging and ER overload in a protein conformational dementia.

Authors:  Angela Schipanski; Sascha Lange; Alexandra Segref; Aljona Gutschmidt; David A Lomas; Elena Miranda; Michaela Schweizer; Thorsten Hoppe; Markus Glatzel
Journal:  Genetics       Date:  2013-01-18       Impact factor: 4.562

5.  Alzheimer's Disease Drug Discovery: In-vivo screening using C. elegans as a model for β-amyloid peptide-induced toxicity.

Authors:  Al Lublin; Cd Link
Journal:  Drug Discov Today Technol       Date:  2013

Review 6.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

7.  PTL-1 regulates neuronal integrity and lifespan in C. elegans.

Authors:  Yee Lian Chew; Xiaochen Fan; Jürgen Götz; Hannah R Nicholas
Journal:  J Cell Sci       Date:  2013-03-22       Impact factor: 5.285

Review 8.  Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.

Authors:  Adam L Boxer; Michael Gold; Edward Huey; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven Khachaturian; Margaret Sutherland; Robert Farese; Bruce L Miller; Jeffrey Cummings
Journal:  Alzheimers Dement       Date:  2012-10-05       Impact factor: 21.566

9.  What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?

Authors:  Dawn Teschendorf; Christopher D Link
Journal:  Mol Neurodegener       Date:  2009-09-28       Impact factor: 14.195

10.  Animal models for Alzheimer's disease and frontotemporal dementia: a perspective.

Authors:  Jürgen Götz; Naeman N Götz
Journal:  ASN Neuro       Date:  2009-11-09       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.